| 2 |
2
제 1 항에 있어서, 상기 면역조절 B 세포는 Fcer2a, Grm6, AU019823, Marcksl1, Bcl2a1c, Bcl2a1d, Afg3l1, Cdk5r1, Cd40, Rrp1b, Slamf1, Luc7l, Igsf9, Gypc, C1qbp, Id3, Il4i1, Gbp1, Cd83, Mybl2, Ift140, Snx11, Swap70, Ccbp2, Sc4mol, Cyp51, Sqle, LOC100040592, B3gnt8, 1300014I06Rik, Fdps, Ctsa, Dmwd, Sfrs7, Hbb-bh1, Hspa1a, Srpk3, Hhex, Insig1, Cbfa2t3h, Taf15, Ddx17, Cnn2, Brwd1, Cr2, Arhgap4, Pira3, Flna, Cdk5rap1, Cugbp1, Ankrd37, Cd44, Mrps7, Mapk11, Pycard, Cap1, Lta, Rbm4, Cd180, Cfp, Cmah, LOC100046855, Srebf1, Ciita, Ryr1, E2f2, Dap3, Wdr9, Ccr6, Pcbd2, Lmnb1, Pira4, Blvrb 또는 Actb 유전자를 고발현하거나 또는 1190002H23Rik, Bhlhb8, Mist1, Fkbp11, Cacna1h, Rsph1, Rbm47, Slpi, Ly6c1, Hist1h1c, Tg, Klra7, Creb3l2, Prg2, Creld2, Nkg7, Anxa2, Txndc5, Tmem66, Amigo2, Klra4, LOC100038894, Speer3, Derl3, Ppapdc1b, Ckb, Thy1, Pqlc3, Klrd1, Xbp1, Klre1, Lgals1, 2010001M09Rik, Ctsw, Cd160, Ccl5, S el1l, Dusp4, Socs2, Ccl4, Cd9, Mcoln2, Trp53inp1, Ssr2, Reln, Tubb2b, Akp2, F2r, H13, Cd8b1, Ifit3, Rsad2, LOC667370, Irf7, Ifit2, Slfn1, Cxcl10, Ctla4, Rgs1, Oasl2, Il7r, Usp18, Mx1, LOC100048346, Mx2, Tyki, Hba-a1, Lgals3bp, Ifitm3, Cfl1, Oas2, Serpina3f, Emb, P2ry14, Cirbp, Dhx58, Fcer1g, Ifng, AA467197, Gpr114, Trafd1, Cd3d, Igtp, Rilpl1, Apoe, Lat, Sh2d2a, Cd6, Slc15a2, Gbp2, Oasl1, Spo11, Ctse, Klf9, Pex11a, D14Ertd668e, Mlkl, Itk, Serpinb6b 또는 Cd69 유전자를 저발현하는 것을 특징으로 하는 면역조절 B 세포
|
